Latest News - CRSTodayEurope

Wednesday, September 20, 2017 | Glaucoma, Aerie Pharmaceuticals

Aerie Pharmaceuticals Announces FDA Advisory Committee Meeting for Rhopressa

Aerie Pharmaceuticals announced that a meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee of the FDA has been scheduled for October 13, 2017 to review the company’s new drug app…

Read the full story

Wednesday, September 20, 2017 | Awards, Prevent Blindness

Prevent Blindness Announces Call for Nominations for 2018 Jenny Pomeroy Award for Excellence in Vision and Public Health

Prevent Blindness is issuing a call for nominations for the 2018 Jenny Pomeroy Award for Excellence in Vision and Public Health. The award recognizes an individual, team, or organization that has made…

Read the full story

Wednesday, September 20, 2017 | Medical Studies

Nerf Guns 'Can Cause Serious Eye Injuries'

Doctors are warning that a toy gun popular with children can cause serious eye injuries. The warning comes after 3 people were treated in an accident and emergency unit after being shot in the eye wit…

Read the full story

Monday, September 18, 2017 | Acquisitions/Mergers, Johnson & Johnson Vision Care

Johnson & Johnson Vision Acquires Sightbox

Johnson & Johnson Vision continues its fast acquisition pace in 2017 after announcing that it has acquired Sightbox, an online, membership-based subscription service for contact lens wearers in th…

Read the full story

Monday, September 18, 2017 | Product Releases

Swiss Advanced Vision Launches Two EDOF IOLs

Swiss Advanced Vision (SAV-IOL) announced the launch of Lucidis and Eden, two new IOLs that use the Instant Focus EDOF patented technology. According to a company news release, Lucidis brings two majo…

Read the full story

Monday, September 18, 2017 | Acquisitions/Mergers, Alcon, ThromboGenics

ThromboGenics Regains Global Rights to Jetrea (Ocriplasmin)

ThromboGenics announced that it will regain full global rights to Jetrea from Alcon based on a mutual agreement that the unique characteristics of Jetrea make Thrombogenics a better fit for building a…

Read the full story

Monday, September 18, 2017 | Corporate Lawsuits, Patents, Allergan

Allergan's Restasis Patent Transfer to Face Precedent-Setting Legal Battle

Allergan caused a lot of hand-wringing in the biotech community and excitement among patent lawyers, when the drugmaker announced it would transfer patents for Restasis, Allergan's longstandi…

Read the full story

Friday, September 15, 2017 | Miscellaneous, Topcon Medical Systems

Topcon Releases Video Interview Series for Aladdin Biometer

Topcon Medical Systems has announcd the release of a series of video interviews where several Key Opinion Leaders talk about their experiences with the Aladdin Biometer with Corneal Topography and how…

Read the full story

Friday, September 15, 2017 | Awards, Prevent Blindness

Prevent Blindness Names Sue Downes of MyEyeDr as 2018 Person of Vision Award Recipient

Prevent Blindness has chosen Sue Downes, CEO at MyEyeDr., as the recipient of the 2018 Prevent Blindness Person of Vision Award. The award will be presented on March 15, 2018, at the Prevent Blindness…

Read the full story

Friday, September 15, 2017 | Medical Studies

Breakthrough Treatments Arriving for Uveal Melanoma

Not long ago, a diagnosis of uveal melanoma meant losing an eye, if the patient was lucky. In the worst cases, it meant chemotherapy followed by a painful death as the cancer spread. But now, speciali…

Read the full story

Friday, September 15, 2017 | FDA Approval/Clearance

FDA Approves First Biosimilar for the Treatment of Cancer

The FDA approved Mvasi (bevacizumab-awwb) as a biosimilar to Avastin (bevacizumab) for the treatment of multiple types of cancer. Mvasi is the first biosimilar approved in the United States for the tr…

Read the full story

Friday, September 15, 2017 | Miscellaneous, American Academy of Ophthalmology

Ophthalmology Organizations Team up to Support Hurricane Survivors

The American Academy of Ophthalmology and the Pan-American Association of Ophthalmology announced that they are establishing a Hurricane Relief Fund in response to the devastation caused by Hurricanes…

Read the full story

Thursday, September 14, 2017 | Product Releases, Carl Zeiss Meditec

Zeiss Unveils Ultra-Widefield Fundus Imaging Technology in US

Zeiss announced the US launch of its next generation, high-definition, ultra-widefield fundus imaging system, CLARUS 500, at the International Vision Expo & Conference in Las Vegas. The CLARUS …

Read the full story

Thursday, September 14, 2017 | Product Releases, Rayner Intraocular Lenses

Rayner Set to Launch RayOne Trifocal at ESCRS

Rayner has announced the launch of the RayOne Trifocal preloaded IOL. The RayOne Trifocal will be unveiled at the upcoming 2017 ESCRS conference in Lisbon, and product availability will begin October …

Read the full story

Thursday, September 14, 2017 | Medical Studies

First Use of Cadaver Nerves to Repair Corneal Anesthesia Shows Promise

A new, minimally invasive procedure that replaces damaged corneal nerves with a donor nerve restores feeling in the cornea and halts progressive eye damage caused by a condition known as corneal anest…

Read the full story
Load More